<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-237 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-237</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-237</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-5.html">extraction-schema-5</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <p><strong>Paper ID:</strong> paper-46945001</p>
                <p><strong>Paper Title:</strong> Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes</p>
                <p><strong>Paper Abstract:</strong> 1Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States 2Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States 3Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States 4Department of Oncologic Science, Morsani College of Medicine, University of South Florida, Tampa, United States 5Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States</p>
                <p><strong>Cost:</strong> 0.01</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e237.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e237.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>US-adenocarcinoma EGFR prevalence</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR mutation prevalence in US non-small cell lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper reports that EGFR mutations have been identified in approximately 15% of lung adenocarcinoma patients in the United States, cited as a baseline prevalence for clinical discussion.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Described broadly as patients with lung adenocarcinoma in the United States (no sample size provided in this paper).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td>â‰ˆ15% (approximately 15% of adenocarcinoma patients in the United States, as reported in the paper)</td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Adenocarcinoma (non-small cell lung cancer)</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Not specified for this prevalence estimate beyond general discussion of smoking elsewhere in the paper.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Not specified for this prevalence estimate (general paper discussion suggests genetic differences may underlie ethnic variation).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>No molecular mechanism provided for this overall prevalence figure; presented as an epidemiologic baseline.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>None specified for this statistic in the paper.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>EGFR mutations are present in roughly 15% of lung adenocarcinoma patients in the U.S., establishing a baseline prevalence for considerations about routine testing and targeted therapy.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes', 'publication_date_yy_mm': '2016-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e237.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e237.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Higher EGFR in Hispanics & East-Asians</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Reported higher frequency of EGFR mutations in Hispanic and East-Asian patients versus non-Hispanic whites</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper summarizes literature reporting that EGFR mutation frequency is higher in Hispanic and East-Asian patients compared with non-Hispanic white patients, and that this may contribute to differential outcomes.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Literature-level comparison across ethnic groups (Hispanic, East-Asian, non-Hispanic white); no single study/sample size reported within this paper for exact frequencies.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>Paper notes Hispanics have a lower frequency of smoke exposure, which has been cited as a partial explanation for improved survival; no numeric breakdown provided.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Associations discussed in the context of NSCLC adenocarcinoma.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Smoking exposure cited (Hispanics reported lower smoking exposure); no other environmental exposures quantified in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Authors state that observed variations 'likely result from genetic differences as opposed to lifestyle choices alone,' but no specific genetic polymorphisms or ancestry markers are provided.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>No detailed biological mechanism proposed; general attribution to underlying genetic/ancestral differences rather than lifestyle alone.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Authors acknowledge potential confounding by access to care, differential healthcare access, insurance status, treatment at comprehensive centers, and possible delays in presentation/treatment.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>The literature summarized by the authors indicates higher EGFR mutation frequencies in Hispanics and East-Asian patients relative to non-Hispanic whites, which may partly explain better survival in some Hispanic populations when combined with lower smoking rates; however, genetic explanations are suggested without specific mechanistic data and access-to-care confounding is emphasized.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes', 'publication_date_yy_mm': '2016-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e237.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e237.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Black patient EGFR frequency</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR mutation frequency in Black (African American) patients</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper notes that Black patients have a lower or similar frequency of EGFR mutations compared with non-Hispanic white patients, according to cited literature.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Reference to comparative literature including African American/Black patients versus non-Hispanic white patients; no sample sizes or direct data provided in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Mentioned in context of NSCLC (adenocarcinoma), but no histology-specific frequencies reported for Black patients in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>The paper highlights that access-to-care and other socioeconomic factors may confound observed racial/ethnic differences in mutation frequencies and outcomes.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Cited literature indicates that Black patients show a lower or similar EGFR mutation frequency relative to non-Hispanic whites, but the paper emphasizes that differences in access to care and other non-biologic factors could influence observed disparities.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes', 'publication_date_yy_mm': '2016-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e237.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e237.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Asian-Indian comparability</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR mutation frequency in Asian-Indian patients comparable to non-Hispanic whites</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper states that EGFR mutation frequency in Asian-Indian patients is comparable to that of non-Hispanic white patients, based on cited studies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Literature-level statement about Asian-Indian patients versus non-Hispanic whites; no primary sample size or numeric frequencies provided here.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Referenced in context of NSCLC/adenocarcinoma.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Implied role of genetic/ancestral differences, but no specific genetic markers provided.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>No mechanism proposed; statement is observational from cited literature.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>No study-level confounders quantified here; paper generally notes potential confounding by access to care and socioeconomic factors.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>According to the literature summarized, Asian-Indian patients have EGFR mutation rates similar to non-Hispanic whites, indicating heterogeneity across Asian subpopulations and underscoring that 'Asian' is not a uniform category in mutation prevalence.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes', 'publication_date_yy_mm': '2016-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e237.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e237.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Hispanic improved survival explanation</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Explanation for improved survival among US Hispanic lung cancer patients</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper attributes better survival among US Hispanic lung cancer patients to a combination of higher EGFR mutation frequency and lower smoking exposure, while acknowledging complexity and potential confounding.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>US Hispanic lung cancer patients as discussed in the literature; no specific cohort numbers provided in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>Paper explicitly notes a lower frequency of smoke exposure among Hispanics (no percentages given) as part of the proposed explanation.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Contextualized within NSCLC, primarily adenocarcinoma where EGFR mutations are clinically relevant.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Lower tobacco smoke exposure among Hispanics cited; no other environmental exposures quantified.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Paper suggests genetic differences may contribute to higher EGFR mutation prevalence in Hispanics but does not specify genetic variants.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Combination of higher somatic EGFR mutation prevalence (genetic/ancestral predisposition) and lower smoking exposure leading to better responses to EGFR TKIs; not elaborated at molecular level.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Authors emphasize alternative explanations including differences in access to care, insurance status, treatment center type, and stage at presentation which may affect survival independent of mutation status.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Improved survival in US Hispanic lung cancer patients has been attributed in the literature to higher EGFR mutation frequency and lower smoking rates, but the paper stresses that access-to-care and other socioeconomic confounders complicate this interpretation and that more systematic testing is needed.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes', 'publication_date_yy_mm': '2016-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER) <em>(Rating: 2)</em></li>
                <li>Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) <em>(Rating: 2)</em></li>
                <li>Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer <em>(Rating: 2)</em></li>
                <li>Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist? <em>(Rating: 2)</em></li>
                <li>Lung adenocarcinoma biomarker incidence in Hispanic versus non-Hispanic white patients <em>(Rating: 2)</em></li>
                <li>Racial differences in lung cancer genetics <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>